195 related articles for article (PubMed ID: 32037878)
1. Diabetes affects endothelial cell function and alters fibrin clot formation in a microvascular flow model: A pilot study.
Jenny L; Melmer A; Laimer M; Hardy ET; Lam WA; Schroeder V
Diab Vasc Dis Res; 2020; 17(1):1479164120903044. PubMed ID: 32037878
[TBL] [Abstract][Full Text] [Related]
2. Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus.
Soma P; Pretorius E
Cardiovasc Diabetol; 2015 Jul; 14():96. PubMed ID: 26228646
[TBL] [Abstract][Full Text] [Related]
3. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
[TBL] [Abstract][Full Text] [Related]
4. Interplay between elevated cellular fibronectin and plasma fibrin clot properties in type 2 diabetes.
Konieczyńska M; Bryk AH; Malinowski KP; Draga K; Undas A
Thromb Haemost; 2017 Aug; 117(9):1671-1678. PubMed ID: 28569923
[TBL] [Abstract][Full Text] [Related]
5. [Microcirculation in diabetes: implications for chronic complications and treatment of the disease].
Aguiar LG; Villela NR; Bouskela E
Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):204-11. PubMed ID: 17505627
[TBL] [Abstract][Full Text] [Related]
6. Deterioration of endothelial function of micro- and macrocirculation in patients with diabetes type 1 and 2.
Besic H; Jeraj L; Spirkoska A; Jezovnik MK; Poredoš P
Int Angiol; 2017 Aug; 36(4):354-361. PubMed ID: 28001011
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome.
Undas A; Wiek I; Stêpien E; Zmudka K; Tracz W
Diabetes Care; 2008 Aug; 31(8):1590-5. PubMed ID: 18487475
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus and coronary microvascular function in asymptomatic patients with severe aortic stenosis and nonobstructed coronary arteries.
Banovic M; Brkovic V; Nedeljkovic I; Nedeljkovic M; Popovic D; Djordjevic-Dikic A; Ristic A; Nikolic S; Beleslin B
Diab Vasc Dis Res; 2016 May; 13(3):220-7. PubMed ID: 26993497
[TBL] [Abstract][Full Text] [Related]
9. Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol.
Joshi MS; Williams D; Horlock D; Samarasinghe T; Andrews KL; Jefferis AM; Berger PJ; Chin-Dusting JP; Kaye DM
Diab Vasc Dis Res; 2015 May; 12(3):208-16. PubMed ID: 25767181
[TBL] [Abstract][Full Text] [Related]
10. Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography.
Maatman BT; Schmeisser G; Kreutz RP
J Diabetes Res; 2018; 2018():4543065. PubMed ID: 29507861
[TBL] [Abstract][Full Text] [Related]
11. Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.
Tehrani S; Jörneskog G; Ågren A; Lins PE; Wallén H; Antovic A
Thromb Haemost; 2015 Feb; 113(2):312-8. PubMed ID: 25318636
[TBL] [Abstract][Full Text] [Related]
12. Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers.
Alzahrani SH; Hess K; Price JF; Strachan M; Baxter PD; Cubbon R; Phoenix F; Gamlen T; Ariëns RA; Grant PJ; Ajjan RA
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2282-7. PubMed ID: 22996148
[TBL] [Abstract][Full Text] [Related]
13. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.
Nyström T; Gutniak MK; Zhang Q; Zhang F; Holst JJ; Ahrén B; Sjöholm A
Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1209-15. PubMed ID: 15353407
[TBL] [Abstract][Full Text] [Related]
14. Skin microvascular function in patients with type 1 diabetes: An observational study from the onset of diabetes.
Santesson P; Lins PE; Kalani M; Adamson U; Lelic I; von Wendt G; Fagrell B; Jörneskog G
Diab Vasc Dis Res; 2017 May; 14(3):191-199. PubMed ID: 28467200
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular complications of diabetes.
Lau DC; Shen GX
Can J Diabetes; 2013 Oct; 37(5):279-81. PubMed ID: 24500552
[No Abstract] [Full Text] [Related]
16. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
17. Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
Kasalová Z; Prázný M; Skrha J
Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):52-7. PubMed ID: 16570233
[TBL] [Abstract][Full Text] [Related]
18. The relationship between sudomotor function and skin microvascular reactivity in individuals with type 1 diabetes of long duration.
Gandecka A; Araszkiewicz A; Piłaciński S; Wierusz-Wysocka B; Zozulińska-Ziółkiewicz D
Microvasc Res; 2018 Nov; 120():84-89. PubMed ID: 30044961
[TBL] [Abstract][Full Text] [Related]
19. MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model.
Jenny L; Dobó J; Gál P; Pál G; Lam WA; Schroeder V
PLoS One; 2018; 13(1):e0191292. PubMed ID: 29324883
[TBL] [Abstract][Full Text] [Related]
20. Flow-Mediated Skin Fluorescence (FMSF) Technique for Studying Vascular Complications in Type 2 Diabetes.
Katarzynska J; Borkowska A; Los A; Marcinek A; Cypryk K; Gebicki J
J Diabetes Sci Technol; 2020 May; 14(3):693-694. PubMed ID: 31855069
[No Abstract] [Full Text] [Related]
[Next] [New Search]
